The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer
- 30 June 2008
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 87 (3), 383-390
- https://doi.org/10.1016/j.radonc.2008.04.011
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: A retrospective studyRadiotherapy and Oncology, 2006
- Cancer of the anal canalThe Lancet Oncology, 2004
- Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.Journal of Clinical Oncology, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Ten-year results of chemoradiation for anal cancer: Focus on late morbidityInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Improved outcome with escalated radiation dosing for anal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin CInternational Journal of Radiation Oncology*Biology*Physics, 1991